StockWatch
·

Research Reports

Fri, 13 Nov
PARKHOSPSPark Medi World Ltd

Park Medi World Q2: consolidated PAT down 31% YoY on margin squeeze, revenue up 25%

hospital chain · margin compression · cost inflation

ResultsQ2 FY273 minPharma & Healthcare
PANACEABIOPANACEA BIOTEC LTD.

Q2 Execution Test: Can the Award Book Turn Into Profits?

vaccine sales · order book execution · UNICEF contract

Result previewQ2 FY273 minPharma & Healthcare
KMCSHILKMC SPECIALITY HOSPITALS (INDIA) LTD.

Margin hold and occupancy trajectory the test after Q1's 120% PAT surge

occupancy · margins · expansion capex

Result previewQ2 FY273 minPharma & Healthcare
DCALDishman Carbogen Amcis Ltd

Recovery in Focus as CDMO Deferrals Unwind

CDMO deferrals · margin recovery · debt raise

Result previewQ2 FY273 minPharma & Healthcare
ORCHPHARMAOrchid Pharma Ltd

Merger Momentum on Test: Dhanuka Integration and FY27 Growth Delivery

Dhanuka merger · Q2 results · merger integration

Result previewQ2 FY273 minPharma & Healthcare
Thu, 12 Nov
GLANDGland Pharma Ltd

Growth Outpacing Margins: A Capex Race Against Guidance

CDMO growth · margin pressure · capex expansion

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
GLANDGland Pharma Ltd

Strong CDMO growth masks margin pressure, capex-heavy path ahead

CDMO momentum · capacity constrained · Cenexi integration

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
SYMBIOTECSymbiotec Pharmalab Ltd

₹280 Crore Quarter Masks Milestone Lumpiness; Guidance Signals Slowdown Ahead

capex intensity · milestone revenue · CDMO fermentation

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
NEPHROPLUSNephrocare Health Services Ltd

Growth held, but margin squeeze and Saudi binary await

dialysis · margin compression · Saudi tender

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
NEPHROPLUSNephrocare Health Services Ltd

Guided growth held, margin squeeze from geographies—Saudi tender outcome critical

international expansion · margin compression · Saudi Arabia tender

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
TARSONSTarsons Products Ltd

Tarsons swings to ₹0.34 Cr consolidated loss in Q2 FY27 despite 21% YoY revenue growth

labware · margin compression · capex depreciation

ResultsQ2 FY273 minPharma & Healthcare
KPLKwality Pharmaceuticals Ltd

Kwality Pharma Q2FY27: consol PAT doubles YoY to ₹29 Cr, margins expand, guidance raised

pharmaceuticals · margin expansion · guidance raised

ResultsQ2 FY273 minPharma & Healthcare
SAILIFESai Life Sciences Ltd

Growth beats guide, but the rally has run to ATH on margin headwinds and capex caution

integrated CRDMO · pharma partnerships · capacity expansion

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
SAILIFESai Life Sciences Ltd

Growth beats guide, partnerships validate strategy; capex delays moderate

integrated CRDMO · pharma partnerships · CRO momentum

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
BLUEJETBlue Jet Healthcare Ltd

Record Growth, Margin Compression—and Silence on Outlook

CDMO · capex · gross margin

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
BLUEJETBlue Jet Healthcare Ltd

Record growth masks margin pressure; capex on track

CDMO platform · capex execution · gross margin

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
KPLKwality Pharmaceuticals Ltd

Kwality Pharma's Growth Inflection — Can Q2 Sustain the Momentum?

pharmaceutical growth · capacity expansion · EU-GMP approval

Result previewQ2 FY273 minPharma & Healthcare
GUFICBIOGUFIC BIOSCIENCES LTD.

Organic growth on track; valuation debate continues

pharma growth · mid-tier domestic · USFDA compliance

Result previewQ2 FY273 minPharma & Healthcare
Wed, 11 Nov
BIOCONBIOCON LTD.

The ₹56.7 Crore Profit Biocon Can't Explain

biosimilars · margin compression · deferral

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
BIOCONBIOCON LTD.

Soft growth, collapsed PAT mar H2 ramp confidence gap

biosimilar launches · margin compression · supply chain headwinds

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
ZIMLABZim Laboratories Ltd

Growth masks deepening losses; EU-GMP is the binary

EU-GMP approval · regulatory catalyst · capex drag

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
ZIMLABZim Laboratories Ltd

18% growth masks deepening losses; EU-GMP approval is make-or-break

EU-GMP approval · margin recovery · revenue growth

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
KOVAIKOVAI MEDICAL CENTER & HOSPITAL LTD.

KMCH Q2 FY27: standalone PAT +31% YoY to ₹77 Cr, margins expand, just misses ₹79-82 Cr view

hospital · margin expansion · standalone pat growth

ResultsQ2 FY273 minPharma & Healthcare
MOLBIOMolbio Diagnostics Ltd

Lumpy Government, Unproven Sequels—25% Growth On Track If Execution Holds

Government diagnostics · TB program · Rate contract delay

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
MOLBIOMolbio Diagnostics Ltd

H1 Miss on Rate Delays, FY27 25% Growth On Track

Government tenders · Truenant platform · Veterinary expansion

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
COHANCESuven Pharmaceuticals Ltd

Sequential bounce masks YoY collapse; H2 growth guidance untested

CDMO · ADC · destocking

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
COHANCESuven Pharmaceuticals Ltd

Sequential recovery masks 14% YoY revenue decline; H2 guidance untested

ADC development funnel · Pharma CDMO destocking · Suryapet restructuring

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
BAFNAPHBAFNA PHARMACEUTICALS LTD.

Bafna Pharma Q2 FY27: PAT doubles YoY to ₹6.85 Cr on margin expansion, revenue +34%

pharmaceuticals formulations · margin expansion · revenue growth

ResultsQ2 FY273 minPharma & Healthcare
POLYMEDPOLY MEDICURE LTD.

Revenue Boom, Profit Lag — Can Poly Restore Growth?

medical devices · acquisition integration · margin recovery

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
POLYMEDPOLY MEDICURE LTD.

Revenue surging, profit stumbling—margin recovery is the test

international expansion · margin compression · acquisition integration

TranscriptDeep diveQ2 FY276 minPharma & Healthcare